Skip to main content
Figure 4 | Cancer Cell International

Figure 4

From: Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells

Figure 4

Effect of 48 h exposure of 5AZA-CdR (5AZA) (10 ng/ml) and/or HDAC inhibitors on loss of clonogenicity of TC71 EWS cells. A) MS-275 (100 ng/ml), B) TSA (2.5 ng/ml), C) Depsi (0.6 ng/ml), D) PB (1 mM), E) LAQ (5 ng/ml). Data shown are mean values ± S.D., n ≥ 3. Statistical analysis: 5AZA + HDAC inhibitor > 5AZA or HDAC inhibitor p < 0.01.

Back to article page